{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:30:28Z","timestamp":1761183028051,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017193","name":"Nichi-Iko Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jiac.2022.12.001","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T11:20:03Z","timestamp":1670671203000},"page":"407-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Toxic shock like syndrome caused by Streptococcus agalactiae bacteremia during treatment for multiple myeloma"],"prefix":"10.1016","volume":"29","author":[{"given":"Mina","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyora","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Maki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Taoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Masamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Wakimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9080-0172","authenticated-orcid":false,"given":"Daisuke","family":"Jubishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoji","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jiac.2022.12.001_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.jiac.2022.12.001_bib2","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrmicro1552","article-title":"Group B Streptococcus: global incidence and vaccine development","volume":"4","author":"Johri","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"10.1016\/j.jiac.2022.12.001_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/322696","article-title":"Group B streptococcal disease in nonpregnant adults","volume":"33","author":"Farley","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jiac.2022.12.001_bib4","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00134-015-3861-7","article-title":"Understanding toxic shock syndrome","volume":"41","author":"Burnham","year":"2015","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jiac.2022.12.001_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MD.0b013e31827dea11","article-title":"Streptococcus agalactiae toxic shock-like syndrome","volume":"92","author":"Al Akhrass","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.jiac.2022.12.001_bib6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2014.00257","article-title":"Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"5","author":"Tete","year":"2014","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jiac.2022.12.001_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/bjc.2011.575","article-title":"The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma","volume":"106","author":"Giannopoulos","year":"2012","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.jiac.2022.12.001_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ejh.13066","article-title":"Risk factors for blood stream infections in multiple myeloma: a population-based study of 1154 patients in Denmark","volume":"101","author":"S\u00f8rrig","year":"2018","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.jiac.2022.12.001_bib9","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.2014.117176","article-title":"European myeloma network guidelines for the management of multiple myeloma-related complications","volume":"100","author":"Terpos","year":"2015","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.jiac.2022.12.001_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-2155-1","article-title":"Risk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma","volume":"17","author":"Huang","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"149","key":"10.1016\/j.jiac.2022.12.001_bib11","article-title":"Streptococcus agalactiae in adults at chiang mai university hospital: a retrospective study","volume":"11","author":"Chaiwarith","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jiac.2022.12.001_bib12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/432804","article-title":"Group B streptococcal infections in elderly adults","volume":"41","author":"High","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jiac.2022.12.001_bib13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/cmi.12531","article-title":"Streptococcal toxins: role in pathogenesis and disease","volume":"17","author":"Barnett","year":"2015","journal-title":"Cell Microbiol"},{"issue":"2","key":"10.1016\/j.jiac.2022.12.001_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/archderm.140.2.163","article-title":"Group B streptococcal toxic shock\u2013like syndrome","volume":"140","author":"Reich","year":"2004","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jiac.2022.12.001_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jiac.2014.12.002","article-title":"Evaluation of streptococcal toxic shock-like syndrome caused by group B streptococcus in adults in Japan between 2009 and 2013","volume":"21","author":"Ikebe","year":"2015","journal-title":"J Infect Chemother"},{"issue":"5","key":"10.1016\/j.jiac.2022.12.001_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1012241117984","volume":"21","author":"Cunningham-Rundles","year":"2001","journal-title":"J Clin Immunol"},{"issue":"21","key":"10.1016\/j.jiac.2022.12.001_bib17","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1182\/blood.V116.21.4070.4070","article-title":"Effect of elotuzumab on circulating lymphocytes, chemokines, and cytokines in multiple myeloma patients","volume":"116","author":"Neyer","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jiac.2022.12.001_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00262-014-1610-3","article-title":"Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-alpha pathways","volume":"64","author":"Balasa","year":"2015","journal-title":"Cancer Immunol Immunother"},{"issue":"17","key":"10.1016\/j.jiac.2022.12.001_bib19","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/blood-2010-04-279893","article-title":"Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma","volume":"116","author":"G\u00f6rg\u00fcn","year":"2010","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jiac.2022.12.001_bib20","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood-2013-05-484782","volume":"122","author":"Lacy","year":"2013","journal-title":"Pomalidomide. Blood."},{"issue":"32","key":"10.1016\/j.jiac.2022.12.001_bib21","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.21.00408","article-title":"Predicted risks of cardiovascular disease following chemotherapy and radiotherapy in the UK NCRI RAPID trial of positron emission tomography\u2013directed therapy for early-stage hodgkin lymphoma","volume":"39","author":"Cutter","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22003245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22003245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:05:14Z","timestamp":1761159914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22003245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1341321X22003245"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.12.001","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxic shock like syndrome caused by Streptococcus agalactiae bacteremia during treatment for multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}